首页 正文

Adaptive nanocarriers targeting tumor systemic intelligence: A paradigm to overcome systemic barriers in precision drug delivery

{{output}}
Biological barriers remain a primary limitation to effective cancer therapy, restricting drug delivery, distribution, and therapeutic efficacy across tumor sites. These barriers arise from a complex and dynamic interplay between tumor- and host-derived factors... ...